Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer
Related Experiment Video
Updated: Feb 9, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Tetsuya Shindo1,2, Takeshi Niinuma2, Naotaka Nishiyama1
1Department of Urology, Sapporo Medical University School of Medicine, Sapporo 060-8543, Japan.
Abstract:
In this study, we identified microRNAs (miRNAs) involved in cisplatin (CDDP) resistance in bladder cancer (BCa). After establishing CDDP-resistant BCa cell lines (T24RC and EJ138RC), TaqMan arrays revealed that members of the miR-200 family (miR-200b, miR-200a and miR-429) were downregulated in T24RC as compared to parental T24 cells. miR-200b was associated with CDDP sensitivity in BCa cells, and its downregulation was associated with CpG island hypermethylation. Pharmacological demethylation using 5-aza-2'-deoxycytidine restored miR-200b expression, and the combination of 5-aza-2'-deoxycytidine + CDDP strongly inhibited T24RC cell proliferation. Microarray analysis revealed that miR-200b + CDDP induced genes involved in CDDP sensitivity or cytotoxicity, including IGFBP3, ICAM1 and TNFSF10, in the resistant cells. Expression and DNA methylation of miR-200b were inversely associated in primary BCa, and low expression/high methylation was associated with poor overall survival. These results suggest downregulation of miR-200b is associated with CDDP resistance in BCa. Epigenetic silencing of miR-200b may be a marker of CDDP resistance and a useful therapeutic target for overcoming CDDP resistance in BCa.
Insights
Downregulation of miR-200b contributes to cisplatin resistance in bladder cancer (BCa). Restoring miR-200b expression via demethylation can re-sensitize BCa cells to cisplatin, offering a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Cisplatin (CDDP) is a cornerstone chemotherapy for bladder cancer (BCa).
- Acquired resistance to CDDP significantly limits treatment efficacy in BCa.
- Understanding the molecular mechanisms underlying CDDP resistance is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To identify microRNAs (miRNAs) implicated in CDDP resistance in BCa.
- To investigate the role of miR-200 family members in CDDP resistance.
- To explore the therapeutic potential of targeting miR-200b epigenetic silencing.
Main Methods:
- Establishment of CDDP-resistant BCa cell lines (T24RC and EJ138RC).
- TaqMan and microarray analyses to profile miRNA and gene expression.
- Assessment of DNA methylation status and its correlation with miRNA expression.
- Pharmacological demethylation using 5-aza-2'-deoxycytidine.
Main Results:
- Members of the miR-200 family, particularly miR-200b, were significantly downregulated in CDDP-resistant BCa cells.
- Downregulation of miR-200b was linked to CpG island hypermethylation.
- Demethylation therapy restored miR-200b expression and enhanced sensitivity to CDDP.
- Combined treatment with 5-aza-2'-deoxycytidine and CDDP inhibited proliferation of resistant cells.
- miR-200b re-expression modulated genes associated with CDDP sensitivity (e.g., IGFBP3, ICAM1, TNFSF10).
- Inverse association between miR-200b expression and methylation was observed in primary BCa, with low expression/high methylation correlating with poor survival.
Conclusions:
- Epigenetic silencing of miR-200b is a key mechanism contributing to CDDP resistance in BCa.
- miR-200b downregulation serves as a potential biomarker for CDDP resistance.
- Targeting miR-200b epigenetic silencing represents a promising therapeutic avenue for overcoming CDDP resistance in BCa.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Treatment Resistant Cancers
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Resistivity
Resistance

